907 related articles for article (PubMed ID: 27468211)
21. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
[TBL] [Abstract][Full Text] [Related]
22. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma.
Persico M; Aglitti A; Caruso R; De Renzo A; Selleri C; Califano C; Abenavoli L; Federico A; Masarone M
Hepatology; 2018 Jan; 67(1):48-55. PubMed ID: 28714143
[TBL] [Abstract][Full Text] [Related]
24. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; De La Red G; Gil V; López-Guillermo A; Ingelmo M; Font J
J Rheumatol; 2004 Mar; 31(3):495-9. PubMed ID: 14994393
[TBL] [Abstract][Full Text] [Related]
25. Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis.
Suarez F; Lefrere F; Besson C; Hermine O
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S32-7. PubMed ID: 17936220
[TBL] [Abstract][Full Text] [Related]
26. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
27. Antiviral therapies for managing viral hepatitis in lymphoma patients.
Merli M; Rattotti S; Gotti M; Arcaini L
Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
[TBL] [Abstract][Full Text] [Related]
28. Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment.
Carbone A; Gloghini A
World J Gastroenterol; 2013 Nov; 19(44):7874-9. PubMed ID: 24307781
[TBL] [Abstract][Full Text] [Related]
29. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
Hermine O; Lefrère F; Bronowicki JP; Mariette X; Jondeau K; Eclache-Saudreau V; Delmas B; Valensi F; Cacoub P; Brechot C; Varet B; Troussard X
N Engl J Med; 2002 Jul; 347(2):89-94. PubMed ID: 12110736
[TBL] [Abstract][Full Text] [Related]
30. Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.
Ennishi D; Terui Y; Yokoyama M; Mishima Y; Takahashi S; Takeuchi K; Okamoto H; Tanimoto M; Hatake K
Am J Hematol; 2008 Jan; 83(1):59-62. PubMed ID: 17712791
[TBL] [Abstract][Full Text] [Related]
31. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
32. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
Mariette X
Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
[TBL] [Abstract][Full Text] [Related]
34. The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.
Vladareanu AM; Ciufu C; Neagu AM; Onisai M; Bumbea H; Vintilescu AM; Dobrea C; Arama V; Mihailescu R; Arama S
J Med Life; 2010; 3(3):320-9. PubMed ID: 20945824
[TBL] [Abstract][Full Text] [Related]
35. Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.
Conca P; Cafaro G; De Renzo A; Coppola A; Cimino E; Tarantino G
Int J Mol Sci; 2015 Jun; 16(6):14075-85. PubMed ID: 26101866
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Silvestri F; Barillari G; Fanin R; Pipan C; Falasca E; Salmaso F; Zaja F; Infanti L; Patriarca F; Botta GA; Baccarani M
Haematologica; 1997; 82(3):314-7. PubMed ID: 9234578
[TBL] [Abstract][Full Text] [Related]
37. From hepatitis C virus infection to B-cell lymphoma.
Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.
Russi S; Sansonno L; Sansonno D
Curr Drug Targets; 2017; 18(7):766-771. PubMed ID: 26844565
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection in non-Hodgkin's lymphoma.
King PD; Wilkes JD; Diaz-Arias AA
Clin Lab Haematol; 1998 Apr; 20(2):107-10. PubMed ID: 9681221
[TBL] [Abstract][Full Text] [Related]
40. NCCN: Non-Hodgkin's lymphoma.
Zelenetz AD; Hoppe RT;
Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]